期刊文献+

原发性胆汁性肝硬化骨髓间充质干细胞的功能研究

Characters of bone marrow mesenchymal stem cells of primary biliary cirrhosis
原文传递
导出
摘要 目的 研究PBC患者的骨髓间充质干细胞(BM-MSC)在生长与外分泌功能方面是否存在异常.方法 取PBC患者及健康对照的新鲜骨髓,体外提取并扩增BM-MSC,以统计学t检验方法比较其在生长情况和分泌细胞因子情况方面的差异.结果 ①PBC患者BM-MSC的生长情况与对照组比较差异无统计学意义;②除TGF-β1在PBC患者BM-MSC上清平均水平低于对照组外[(2.6±1.9)与(8.2±6.7) ng/ml,t=-3.641,P=0.001],PBC患者与对照组的BM-MSC在细胞因子分泌功能方面基本一致;③对照组第5代以内的BM-MSC不同代次之间在细胞因子分泌方面功能基本相同,仅在IL-10[原代与第3代(18.5±5.0)与(12.4±3.1) pg/ml,t=2.368,P=0.045]、肝细胞生长因子[原代与第2代(0.21±0.07)与(0.35±0.08) ng/ml,t=-2.874,P=0.021]水平有小范围波动.结论 PBC患者的BM-MSC在生长情况及细胞因子分泌功能方面,除TGF-β1水平略低外,与对照比较差异无统计学意义.对照组MSC第2代细胞可能更适合治疗PBC. Objective To investigate the growth and exocrine function of BM-MSC derived from PBC patients.Methods To compare the growth patterns and cytokines secretions between PBC patients and healthy controls by student's t test.Results ① There was no difference in growth profile and speed between PBC patients and healthy controls.② The level of TGF-β1 was much lower in the supernatant of BM-MS from OBC patients than health controls [(2.6±1.9)vs (8.2±6.7)ng/ml,t=-3.641,P=0.001].There were no other differences between two groups' BM-MSC.③ The super natant concentration of interlukin-10 of the third BM-MSC subculture from healthy controls was lower than that of the primary subculture [(18.5±5.0) vs (12.4±3.1) pg/ml,t=2.368,P=0.045],and that of hepatic growth factor from the second subcuhure was higher than the primary subculture [(0.21±0.07) vs (0.35±0.08) ng/ml,t=-2.874,P=0.021].There were seldom discrepancies in other cytokines between different generations of BM-MSC.Conclusion BM-MSC from PBC patients may have almost the similar characters in growth pattern and cytokines secretion as,except the TGF-β1,which was much lower than those from healthy controls.The second subculture of BM-MSC might be more suitable for the treatment to patients with PBC.
出处 《中华风湿病学杂志》 CAS CSCD 北大核心 2014年第11期726-729,共4页 Chinese Journal of Rheumatology
基金 国家高技术研究发展计划(863计划)(201IAA020111) 国家科技重大专项“重大新药创制”(2012ZX0.9303006.002) 卫生公益性行业科研专项(201202004)
关键词 肝硬化 胆汁性 间充质干细胞 细胞因子 Liver cirrhosis,biliary Mesenchymal stem cells Cytokines
  • 相关文献

参考文献11

  • 1王立,韩钦,陈华,孔芳,杨云娇,赵岩,李永哲,张烜,崔全才,卢朝辉,张奉春,赵春华.骨髓间充质干细胞移植治疗难治型原发性胆汁性肝硬化初探[J].中华风湿病学杂志,2013,17(9):580-584. 被引量:6
  • 2Lindor KD,Gershwin ME,Poupon R.Primary biliary cirrhosis[J].Hepatology,2009,50:291-308.
  • 3Bocelli-Tyndall C,Bracci L,Spagnoh G,et al.Bone marrow mesenchymal stromal cells (BM-MSC) from healthy donors and auto-immune disease patients reduce the proliferation of autologous-and allogenic-stimulated lymphocytes in vitro[J].Rheumatology,2007,46:403-408.
  • 4Larghero J,Farge D,Braccini A,et al.Phenotypical and functional characteristics of in vitro expanded bone marrow mesenchymal stem cells from patients with systemic sclerosis[J].Ann Rheum Dis,2008,67:443-449.
  • 5Cipriani P,Guiducci S,Miniati I,et al.Impairment of endothelial cell differentiation from bone marrow-derived mesenchymal stem cells:new insight into the pathogenesis of systemic sclerosis[J].Arthritis Rheum,2007,56:1994-2004.
  • 6Sun LY,Zhang HY,Feng XB,et al.Abnormality of bone marrowderived stem cell in patient with systemic lupus erythematosus[J].Lupus,2007,16:121-128.
  • 7Dudics V,Kunstár A,Kovács J,et al.Chondrogenic potential of mesenchymal stem cells from patients with rheumatoid arthritis and osteoarthritis:measurements in a microculture system[J].Cells Tissus Organs,2009,189:307-316.
  • 8Sudeepta A,Pitterger MF.Human mesenchymal stem cells modulate allogenic immune cell response[J].Blood,2005,10:285-288.
  • 9Jenhani F,Durand V,Ben Azouna N,et al.Human cytokine expression profile in various conditioned media for in vitro expansion bone marrow and umbilical cord blood immunophenotyped mesenchymal stem cells[J].Trans Proceed,2011,43:639-643.
  • 10Zhou L,Lopes JE,Chong MM,et al.TGF-beta-induced Foxp3 inhibits Thl7 cell differentiation by antagonizing RORgamma function[J].Nature,2008,455:236-240.

二级参考文献18

  • 1Poupon R. Primary biliary cirrhosis: a 2010 update. J Hepatol, 2010, 52: 745-758.
  • 2Le Blanc K, Frassoni F, Ball L, et al. Mesenchymal stem ceils for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase Ⅱ study. Lancet, 2008, 371: 1579-1586.
  • 3Lindor KD, Gershwin ME, Poupon R. Primary biliary cirrhosis. Hepatology, 2009, 50: 291-308.
  • 4Corpechot C, Abenacoli L, Rabahi N, et al. Biochemical re- sponse to ursodeoxycholic acid and long-term prognosis in pri- mary biliary cirrhosis. Hepatology, 2008, 48: 871-877.
  • 5Ludwig J, Diekson ER, McDonald GS. Staging of chronic non- suppurative destructive cholangitis (syndrome of primary biliary cirrhosis). Virehows Arch A Pathol Anat Histol, 1978, 379: 103-112.
  • 6Seheuer PJ. Primary biliary cirrhosis: diagnosis, pathology and pathogenesis. Postgrad Med J, 1983, 59: 106-115.
  • 7Ludwig J. The pathology of primary biliary cirrhosis and autoim- mune eholangitis. Baillieres Best Pract Res Clin Gastroenterol, 2000, 14: 601-613.
  • 8Jacoby A, Rannard A, Buck D, et al. Development, validation, and evaluation of the PBC-40, a disease specific health related quality of life measure for primary biliary cirrhosis. Gut, 2005, 54: 1622-1629.
  • 9Sun L, Wang D, Liang J, et al. Umbilical cord mesenchymal stem cell transplantation in severe and refractory systemic lupus erythematosus. Arthritis Rheum, 2010, 62: 2467-2475.
  • 10Zhang LN, Shi TY, Zhang FC, et al. Early biochemical response to ursodeoxycholic acid and long-term prognosis of primary biliary cirrhosis: results of a 14-year cohort study. Hepatology, 2013, 58 : 264-272.

共引文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部